571 related articles for article (PubMed ID: 26185901)
21. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
[TBL] [Abstract][Full Text] [Related]
22. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
23. Identification of Substrates of Protein-Group SUMOylation.
Psakhye I; Jentsch S
Methods Mol Biol; 2016; 1475():219-31. PubMed ID: 27631809
[TBL] [Abstract][Full Text] [Related]
24. Introduction to Sumoylation.
Wilson VG
Adv Exp Med Biol; 2017; 963():1-12. PubMed ID: 28197903
[TBL] [Abstract][Full Text] [Related]
25. Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
Hendriks IA; Lyon D; Young C; Jensen LJ; Vertegaal AC; Nielsen ML
Nat Struct Mol Biol; 2017 Mar; 24(3):325-336. PubMed ID: 28112733
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Sumoylation.
Breucker J; Pichler A
Methods Mol Biol; 2019; 1934():223-233. PubMed ID: 31256382
[TBL] [Abstract][Full Text] [Related]
27. Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.
Filosa G; Barabino SM; Bachi A
Neuromolecular Med; 2013 Dec; 15(4):661-76. PubMed ID: 23979992
[TBL] [Abstract][Full Text] [Related]
28. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
29. SUMO proteases as potential targets for cancer therapy.
Bialik P; Woźniak K
Postepy Hig Med Dosw (Online); 2017 Dec; 71(0):997-1004. PubMed ID: 29225200
[TBL] [Abstract][Full Text] [Related]
30. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.
Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC
Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634
[TBL] [Abstract][Full Text] [Related]
31. Roles for SUMO modification during senescence.
Andreou AM; Tavernarakis N
Adv Exp Med Biol; 2010; 694():160-71. PubMed ID: 20886763
[TBL] [Abstract][Full Text] [Related]
32. System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.
Xiao Z; Chang JG; Hendriks IA; Sigurðsson JO; Olsen JV; Vertegaal AC
Mol Cell Proteomics; 2015 May; 14(5):1419-34. PubMed ID: 25755297
[TBL] [Abstract][Full Text] [Related]
33. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
34. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
Tang Z; Hecker CM; Scheschonka A; Betz H
FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
[TBL] [Abstract][Full Text] [Related]
35. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin proteolytic system: focus on SUMO.
Wilson VG; Heaton PR
Expert Rev Proteomics; 2008 Feb; 5(1):121-35. PubMed ID: 18282128
[TBL] [Abstract][Full Text] [Related]
37. Reconstitution of Arabidopsis thaliana SUMO pathways in E. coli: functional evaluation of SUMO machinery proteins and mapping of SUMOylation sites by mass spectrometry.
Okada S; Nagabuchi M; Takamura Y; Nakagawa T; Shinmyozu K; Nakayama J; Tanaka K
Plant Cell Physiol; 2009 Jun; 50(6):1049-61. PubMed ID: 19376783
[TBL] [Abstract][Full Text] [Related]
38. Label-Free Identification and Quantification of SUMO Target Proteins.
Hendriks IA; Vertegaal AC
Methods Mol Biol; 2016; 1475():171-93. PubMed ID: 27631806
[TBL] [Abstract][Full Text] [Related]
39. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
40. Current Status of SUMOylation Inhibitors.
Brackett CM; Blagg BSJ
Curr Med Chem; 2021; 28(20):3892-3912. PubMed ID: 32778019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
